Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

ClinicalTrials.gov ID: NCT01672853

Public ClinicalTrials.gov record NCT01672853. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 11:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase Like 2 (LOXL2) in Subjects With Primary Sclerosing Cholangitis (PSC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate whether simtuzumab (GS-6624) is effective at preventing the progression of liver fibrosis in adults with primary sclerosing cholangitis (PSC).

Study identification

NCT ID
NCT01672853
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
235 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 4, 2013 (Actual)
Primary completion
Aug 8, 2016 (Actual)
Completion
Aug 24, 2016 (Actual)
Last update posted
Oct 22, 2019

2013 – 2016

United States locations

U.S. sites
43
U.S. states
23
U.S. cities
37
Facility City State ZIP Site status
Mayo Clinic Hospital Phoenix Arizona 85054 —
University of Arizona Health Sciences Center Tucson Arizona 85724 —
Southern California Liver Center Chula Vista California 91910 —
Southern California Liver Centers Coronado California 92118 —
Scripps Clinic La Jolla California 92037 —
Verterans Adminstration Hospital Palo Alto California 94304 —
UC Davis Medical Center Sacramento California 95817 —
University of San Diego Medical Center San Diego California 92103 —
University of California San Francisco San Francisco California 94143 —
University of Colorado Denver Aurora Colorado 80045 —
University of Miami Center for Liver Diseases Miami Florida 33136 —
Northwestern University Chicago Illinois 60611 —
Indiana University Indianapolis Indiana 46202 —
Indianapolis Gastroenterology Research Foundation Indianapolis Indiana 46237 —
Iowa Digestive Disease Center Clive Iowa 50325 —
University of Louisville Louisville Kentucky 40202 —
Tulane University Health Sciences Center New Orleans Louisiana 70112 —
Walter Reed National Military Medical Center Bethesda Maryland 20889 —
Beth Israel Deaconess Medical Center Boston Massachusetts 01125 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Minnesota Gastroenterology, PA Saint Paul Minnesota 55114 —
St. Louis University St Louis Missouri 63104 —
Weill Cornell Medical College New York New York 10021 —
Mount Sinai Hospital New York New York 10029 —
Duke Clinical Research Institute Durham North Carolina 27710 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
Cleveland Clinic Cleveland Ohio 44195 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University Gastroenterology Providence Rhode Island 02905 —
Vanderbilt University Medical Center Nashville Tennessee 37212 —
UT Southwestern Medical Center Dallas Texas 75390 —
Brooke Army Medical Center Fort Sam Houston Texas 78234 —
St. Luke Episcopal Hospital Houston Texas 77030 —
Alamo Medical Research San Antonio Texas 78215 —
Intermountain Medical Center Murray Utah 84107 —
University of Utah Salt Lake City Utah 84132 —
University of Virginia Health Center Charlottesville Virginia 22908 —
Liver Institute of Virginia Newport News Virginia 23603 —
Digestive and Liver Disease Specialists Norfolk Virginia 23502 —
Bon Secours Richmond Health System Richmond Virginia 23226 —
Virginia Commonwealth University Health System Richmond Virginia 23298 —
Virginia Mason Medical Center Seattle Washington 98101 —
University of Washington Seattle Washington 98103 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01672853, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2019 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01672853 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →